ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,000 | -95.1% | 125 | -92.4% | 0.00% | -95.0% |
| Q3 2020 | $61,000 | +134.6% | 1,650 | +230.0% | 0.02% | +100.0% |
| Q2 2020 | $26,000 | +85.7% | 500 | +11.1% | 0.01% | +66.7% |
| Q1 2020 | $14,000 | -22.2% | 450 | +50.0% | 0.01% | -14.3% |
| Q4 2019 | $18,000 | +63.6% | 300 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $11,000 | -21.4% | 300 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $14,000 | +16.7% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $12,000 | -14.3% | 300 | 0.0% | 0.01% | -33.3% |
| Q4 2018 | $14,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |